You are browsing the global website, which contains information intended for residents outside of the United States of America (U.S.). This website is not country-specific and therefore may contain information that is not applicable to your country.
Rare Cells, with Single Cell Precision
We offer a menu of FDA-cleared and laboratory-developed tests (LDTs) used to detect and analyze circulating tumor cells in human blood with CELLSEARCH®. This minimally invasive liquid biopsy approach allows these tests to enable optimized patient care and comfort throughout the patient’s therapeutic journey.
Learn more about our Oncology portfolio
Learn more about our commitment in cell-based noninvasive prenatal testing (CB-NIPT)
Find out more about billing options
Learn more about setting up your account and ordering a test
If you already have an existing portal account, you can login here
Discover how our clinical lab service can support biopharma partners and clinical trials
Discover how our custom research lab service can support research projects
Single Cell Analysis
FFPE Analysis
View our complete list of Laboratory Developed Tests
Read the latest news from the Menarini Group
At Menarini Silicon Biosystems, we believe that the way forward in oncology is through personalized patient care.
Through our groundbreaking technology platforms and global lab services, we have standardized serial monitoring through cell-based liquid biopsy for a variety of conditions.
Our solutions empower doctors, clinical researchers and biopharma companies involved in clinical trials, to evaluate precious real-time information about cancer via a simple blood draw contributing to more comprehensive patient care.
The Gold Standard IVD Test for CTC enumeration
READ MORE
Non-invasive assay to monitor multiple myeloma disease
For Biopharma and Research center
Our technologies and products help uncover the biological complexities of cancer by enabling rare cells analysis with single cell precision.
Read More
Login
